InvestSMART

Proteomics International Laboratories Ltd (ASX: PIQ) - Announcements

Current share price for PIQ : $0.098 0.002 (2%)+

ASX company news and announcements for Proteomics International Laboratories Ltd (PIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Proteomics International Laboratories Ltd (PIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Proteomics International Laboratories Ltd (PIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Proteomics International Laboratories Ltd (PIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$16 Security Purchase Plan Offer Booklet Update 6 Nov 2026 11:59AM $0.096 $0.098 risen by 2.08%
$16 Amended Notice of Annual General Meeting/Proxy Form 5 Nov 2026 4:37PM $0.100 $0.098 fallen by 2%
$16 Investor Webinar Presentation 4 Nov 2026 11:34AM $0.095 $0.098 risen by 3.16%
$16 Security Purchase Plan Offer Booklet 4 Nov 2026 10:59AM $0.095 $0.098 risen by 3.16%
$16 Share Purchase Plan Cleansing Notice 4 Nov 2026 9:59AM $0.095 $0.098 risen by 3.16%
$16 Proposed issue of securities - PIQ 2 Nov 2026 9:31AM $0.120 $0.098 fallen by 18.33%
$16 Proteomics International Launches Share Purchase Plan 2 Nov 2026 9:12AM $0.120 $0.098 fallen by 18.33%
$16 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2026 5:02PM $0.120 $0.098 fallen by 18.33%
$16 National Rollout of PromarkerD and PromarkerEso 23 Oct 2026 8:33AM $0.115 $0.098 fallen by 14.78%
$16 Notice of Annual General Meeting/Proxy Form 22 Oct 2026 10:23AM $0.115 $0.098 fallen by 14.78%
$16 Proteomics International receives $2.0m in R&D tax incentive 21 Oct 2026 9:50AM $0.115 $0.098 fallen by 14.78%
$16 Ignite Investment Summit Presentation 14 Oct 2026 8:41AM $0.140 $0.098 fallen by 30%
$16 PromarkerEndo Validation and Refinement Complete 13 Oct 2026 8:43AM $0.130 $0.098 fallen by 24.62%
$16 Notice of AGM Date 24 Sep 2026 2:53PM $0.120 $0.098 fallen by 18.33%
$16 Investor Presentation 23 Sep 2026 9:58AM $0.135 $0.098 fallen by 27.41%
$16 PromarkerD and PromarkerEso Commercial Rollout Update 14 Sep 2026 9:47AM $0.140 $0.098 fallen by 30%
$16 Appendix 4E and Annual Report 31 Aug 2026 4:35PM $0.150 $0.098 fallen by 34.67%
$16 Appendix 4G and Corporate Governance Statement 31 Aug 2026 4:32PM $0.150 $0.098 fallen by 34.67%
$16 Australian patent for PromarkerEndo 13 Aug 2026 8:46AM $0.155 $0.098 fallen by 36.77%
$16 Change in substantial holding 5 Aug 2026 8:17AM $0.140 $0.098 fallen by 30%
$16 Quarterly Activities/Appendix 4C Cash Flow Report 27 Jul 2026 9:48AM $0.155 $0.098 fallen by 36.77%
$16 Webinar Presentation - Healius distribution agreement 23 Jul 2026 9:29AM $0.185 $0.098 fallen by 47.03%
$16 Proteomics signs national distribution deal with Healius 22 Jul 2026 8:30AM $0.150 $0.098 fallen by 34.67%
$16 Application for quotation of securities - PIQ 13 Jul 2026 8:24AM $0.205 $0.098 fallen by 52.20%
$16 US patent secured for PromarkerEndo 8 Jul 2026 10:09AM $0.160 $0.098 fallen by 38.75%

1 - 25 of 709 results

Page 1 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.